Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

2003911 citationsJournal Articlebronze Open Access

Authors

Takeshi Mimura · St Mark's Hospital

F Rizzello · University of Bologna

U Helwig · University of Bologna

G Poggioli · University of Bologna

S Schreiber · Kiel University

I C Talbot · St Mark's Hospital

R J Nicholls · St Mark's Hospital

P Gionchetti ·

Abstract

The once daily high dose probiotic VSL#3 is effective in maintaining antibiotic introduced remission for at least a year in patients with recurrent or refractory pouchitis. This is associated with a high level of quality of life.

Topics & Keywords

Helicobacter pylori-related gastroenterology studies Celiac Disease Research and Management Probiotics and Fermented Foods

Publication Details

Published in: Gut

Volume 53, Issue 1, pp. 108-114

DOI: 10.1136/gut.53.1.108

Field-Weighted Citation Impact: 43.36

Command Palette

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Authors

Abstract

Topics & Keywords

Publication Details